Amplification of CCNE1 is associated with many cancer progressions including gastric cancer, bladder cancer, ovarian cancer and triple negative breast cancer and linked to poor prognosis.40, 41, 42, 43. Here, CCNE1 is linked to urinary bladder cancer.